BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
37 results:

  • 1. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Necroptosis-Related Gene Signature to Predict the prognosis of skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.
    Onieva JL; Xiao Q; Berciano-Guerrero MÁ; Laborda-Illanes A; de Andrea C; Chaves P; Piñeiro P; Garrido-Aranda A; Gallego E; Sojo B; Gálvez L; Chica-Parrado R; Prieto D; Pérez-Ruiz E; Farngren A; Lozano MJ; Álvarez M; Jiménez P; Sánchez-Muñoz A; Oliver J; Cobo M; Alba E; Barragán I
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012390
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
    Pennington TE; Zhao CY; Colebatch AJ; Fernandez-Peñas P; Guitera P; Burke H; Scolyer RA; Menzies AM; Carlino MS; Lo S; Long GV; Saw RP
    Australas J Dermatol; 2022 May; 63(2):e133-e137. PubMed ID: 35188271
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. B cell-related gene signature and cancer immunotherapy response.
    Lundberg A; Li B; Li R
    Br J Cancer; 2022 Apr; 126(6):899-906. PubMed ID: 34921229
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.
    Ovilla-Martinez R; Weber Sánchez LA; Cota-Rangel X; Baez-Islas PE
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764108
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retrospective review of cutaneous metastasis among 11,418 patients with solid malignancy: A tertiary cancer center experience.
    Teyateeti P; Ungtrakul T
    Medicine (Baltimore); 2021 Jul; 100(29):e26737. PubMed ID: 34398051
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
    Sinit RB; Hwang DG; Vishnu P; Peterson JF; Aboulafia DM
    BMC Cancer; 2019 Nov; 19(1):1147. PubMed ID: 31775673
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
    Ducharme O; Beylot-Barry M; Pham-Ledard A; Bohers E; Viailly PJ; Bandres T; Faur N; Frison E; Vergier B; Jardin F; Merlio JP; Gros A
    J Invest Dermatol; 2019 Nov; 139(11):2334-2342.e8. PubMed ID: 31150604
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases].
    Kurosawa S; Sekiya N; Muraosa Y; Kamei K; Nagata A; Yamada Y; Konishi T; Takezaki T; Kaito S; Sakaguchi M; Harada K; Yasuda S; Yoshioka K; Inamoto K; Toya T; Igarashi A; Najima Y; Muto H; Doki N; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Rinsho Ketsueki; 2017; 58(12):2375-2379. PubMed ID: 29332869
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical characteristics of 6 patients with blastic plasmacytoid dendritic cell neoplasm].
    Han X; Ouyang MQ; Pei Q; Duan MH; Jiang XY; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):700-705. PubMed ID: 28954350
    [No Abstract]    [Full Text] [Related]  

  • 12. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
    Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
    Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
    Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Infant acute leukemia].
    Brethon B; Cavé H; Fahd M; Baruchel A
    Bull Cancer; 2016 Mar; 103(3):299-311. PubMed ID: 26826739
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
    Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
    J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Is melanoma survival influenced by month of diagnosis?
    Savoye I; Jegou D; Kvaskoff M; Rommens K; Boutron-Ruault MC; Coppieters Y; Francart J
    Cancer Epidemiol; 2015 Oct; 39(5):727-33. PubMed ID: 26220880
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recurrence and survival after neck dissections in cutaneous head and neck melanoma.
    Andersen PS; Chakera AH; Thamsborg AK; Kølle SF; Schmidt G; Klyver H; Drzewiecki KT
    Dan Med J; 2014 Dec; 61(12):A4953. PubMed ID: 25441725
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
    Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
    Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Histiocytic sarcoma:a clinicopathologic study of 4 cases].
    Jiang QM; Zhou WW; Song R; Ye XZ; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):751-5. PubMed ID: 23336231
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidence of second malignancies during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors in the Czech Republic and Slovakia.
    Voglova J; Muzik J; Faber E; Zackova D; Klamova H; Steinerova K; Michalovicova Z; Demitrovicova L; Cmunt E; Novakova L; Tothova E; Belohlavkova P; Mayer J; Indrak K
    Neoplasma; 2011; 58(3):256-62. PubMed ID: 21395367
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.